Toshitaka Nagao

8.8k total citations · 1 hit paper
244 papers, 5.6k citations indexed

About

Toshitaka Nagao is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshitaka Nagao has authored 244 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Surgery, 108 papers in Oncology and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshitaka Nagao's work include Salivary Gland Tumors Diagnosis and Treatment (80 papers), Ear and Head Tumors (61 papers) and Oral and Maxillofacial Pathology (47 papers). Toshitaka Nagao is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (80 papers), Ear and Head Tumors (61 papers) and Oral and Maxillofacial Pathology (47 papers). Toshitaka Nagao collaborates with scholars based in Japan, United States and Sweden. Toshitaka Nagao's co-authors include Jun Matsubayashi, Reisuke H. Takahashi, Gunnar K. Gouras, Isamu Sugano, Yōichirō Kondō, Kōichi Nagao, Norihiko Ikeda, Yasuo Ishida, Tatsuo Ohira and Akiyoshi Konno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Toshitaka Nagao

220 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

2010 531 citations Toshitaka Nagao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshitaka Nagao Japan	39	2.7k	2.5k	1.3k	1.0k	920	244	5.6k
Tetsunari Oyama Japan	43	1.3k 0.5×	2.8k 1.1×	1.0k 0.8×	2.9k 2.8×	143 0.2×	281	7.2k
Marvin M. Romsdahl United States	36	1.3k 0.5×	2.2k 0.9×	3.2k 2.6×	688 0.7×	456 0.5×	89	5.8k
Reetesh K. Pai United States	41	2.5k 0.9×	2.5k 1.0×	783 0.6×	1.1k 1.1×	103 0.1×	164	5.8k
Yoshiaki Inayama Japan	35	1.0k 0.4×	1.2k 0.5×	1.5k 1.2×	1.2k 1.2×	111 0.1×	194	3.9k
Zenya Naito Japan	39	962 0.4×	1.2k 0.5×	697 0.6×	1.9k 1.9×	131 0.1×	248	4.5k
Niki J. Agnantis Greece	32	758 0.3×	1.4k 0.5×	543 0.4×	1.5k 1.5×	135 0.1×	182	4.1k
Janusz Ryś Poland	30	835 0.3×	1.3k 0.5×	1.5k 1.2×	1.0k 1.0×	67 0.1×	170	4.0k
Chien‐Feng Li Taiwan	46	1.1k 0.4×	2.2k 0.9×	1.7k 1.3×	4.4k 4.3×	213 0.2×	322	8.2k
Thomas Knösel Germany	38	627 0.2×	1.6k 0.6×	1.2k 1.0×	1.5k 1.5×	157 0.2×	176	4.3k
Kyubo Kim South Korea	28	1.1k 0.4×	1.3k 0.5×	884 0.7×	577 0.6×	64 0.1×	211	3.2k

Countries citing papers authored by Toshitaka Nagao

Since Specialization

Citations

This map shows the geographic impact of Toshitaka Nagao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshitaka Nagao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshitaka Nagao more than expected).

Fields of papers citing papers by Toshitaka Nagao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshitaka Nagao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshitaka Nagao. The network helps show where Toshitaka Nagao may publish in the future.

Co-authorship network of co-authors of Toshitaka Nagao

This figure shows the co-authorship network connecting the top 25 collaborators of Toshitaka Nagao. A scholar is included among the top collaborators of Toshitaka Nagao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshitaka Nagao. Toshitaka Nagao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakaguro, Masato, Doreen N. Palsgrove, Jeffrey Gagan, et al.. (2025). 12q Amplification Characterizes a Distinctive Salivary Gland Tumor with Bizarre Myoepithelial Atypia. Head and Neck Pathology. 19(1). 31–31.

Goto, Keisuke, Thibault Kervarrec, Anne Tallet, et al.. (2024). Hidrocystoma-like tumours with RET or ALK fusion: a study of four cases. Pathology. 56(6). 865–873. 1 indexed citations

Ohno, Yoshio, et al.. (2024). A case of adrenal oncocytoma: reviewing the literature of radiological finding. BJR|case reports. 10(5). uaae029–uaae029. 1 indexed citations

Sakamoto, Hiroki, Takao Hashimoto, Jun Matsubayashi, et al.. (2024). A Cerebral Embolism Caused by a Malignant Peripheral Nerve Sheath Tumor in a Patient with Neurofibromatosis Type 1. Internal Medicine. 63(22). 3087–3091.

Saito, Akira, Takeshi Hashimoto, Naoya Satake, et al.. (2023). Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features. Scientific Reports. 13(1). 11035–11035. 3 indexed citations

Usui, Yoshihiko, et al.. (2023). Immunophenotypic profiles in chalazion and pyogenic granuloma associated with chalazion. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(4). 1329–1335.

Saito, Akira, Koji Fujita, Masaharu Kobayashi, et al.. (2023). Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues. The Journal of Pathology Clinical Research. 9(3). 182–194. 6 indexed citations

Murase, Takayuki, Toshitaka Nagao, Kimihide Kusafuka, et al.. (2021). Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological features. Histopathology. 80(4). 729–735. 14 indexed citations

Yoshizawa, Akihiko, Kenzo Hiroshima, Akemi Takenaka, et al.. (2021). Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions. Acta Cytologica. 66(2). 124–133. 10 indexed citations

10.

Ishigami, Tomoaki, Hirofumi Tomiyama, Yuko Kato, et al.. (2021). Increased Plasma Levels of Myosin Heavy Chain 11 Is Associated with Atherosclerosis. Journal of Clinical Medicine. 10(14). 3155–3155. 2 indexed citations

11.

Nishimura, Michiko, Kaoru Kusama, Hideaki Sakashita, et al.. (2021). A Case of Buccal Clear Cell Carcinoma Caused by Rare Fusion Gene: EWSR1-CREM. Case Reports in Dentistry. 2021(1). 1 indexed citations

12.

Ito, Tatsuya, Hiroki Sato, Takahiro Tsujikawa, et al.. (2020). Neck dissection prolongs survival in patient with stage IVC hypopharyngeal carcinoma with mixed responses to nivolumab. Auris Nasus Larynx. 48(2). 322–326. 4 indexed citations

13.

Hiroshima, Kenzo, Akihiko Yoshizawa, Akemi Takenaka, et al.. (2020). Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and Japanese Society of Clinical Cytology: An Interobserver Reproducibility Study and Risk of Malignancy Evaluation on Cytology Specimens. Acta Cytologica. 64(5). 452–462. 21 indexed citations

14.

Takahashi, Hideaki, Yuichiro Tada, Takashi Saotome, et al.. (2018). Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma. Journal of Clinical Oncology. 37(2). 125–134. 155 indexed citations

15.

Kurata, Atsushi, Masakatsu Takanashi, Hirotsugu Hashimoto, et al.. (2018). Fascin as a Useful Marker for Identifying Neural Components in Immature Teratomas of Human Ovary and Those Derived From Murine Embryonic Stem Cells. International Journal of Gynecological Pathology. 38(4). 377–385. 1 indexed citations

16.

Yamada, Masatoshi, Akira Saito, Yoichiro Yamamoto, et al.. (2016). Quantitative nucleic features are effective for discrimination of intraductal proliferative lesions of the breast. Journal of Pathology Informatics. 7(1). 1–1. 12 indexed citations

17.

Oshiro, Hisashi, Masahiro Miura, Yoshihito Shimazu, et al.. (2014). Lymphatic Stomata in the Adult Human Pulmonary Ligament. Lymphatic Research and Biology. 13(2). 137–145. 9 indexed citations

18.

Mascaux, Céline, Murry W. Wynes, Yasufumi Kato, et al.. (2011). EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology. Clinical Cancer Research. 17(24). 7796–7807. 29 indexed citations

19.

Nagao, Toshitaka, Thomas A. Gaffey, Daniel W. Visscher, et al.. (2004). Invasive Micropapillary Salivary Duct Carcinoma. The American Journal of Surgical Pathology. 28(3). 319–326. 137 indexed citations

20.

Ishizuka, Y., et al.. (1992). Tissue developmental anomalies of Coati's organ of the inner ear in experimental cretin rats : Abstracts of Papers Presented at the Thirty-Second Annual Meeting of the Japanese Teratology Society Tokyo, Japan, July 8-10, 1992. Congenital Anomalies. 32(3). 257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact